151 related articles for article (PubMed ID: 22971686)
1. Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study.
Skolarikos A; Tyritzis S; Stamatiou K
Minerva Urol Nefrol; 2012 Sep; 64(3):209-16. PubMed ID: 22971686
[TBL] [Abstract][Full Text] [Related]
2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
3. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
Lo KL; Chan MC; Wong A; Hou SM; Ng CF
Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
[TBL] [Abstract][Full Text] [Related]
5. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
McNeill SA; Hargreave TB; Roehrborn CG;
Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
Alan McNeill S
Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
[TBL] [Abstract][Full Text] [Related]
7. Does acute urinary retention respond to alpha-blockers alone?
McNeill SA
Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
Bhomi KK; Bhattachan CL
Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
[TBL] [Abstract][Full Text] [Related]
9. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
Int J Urol; 2004 Feb; 11(2):88-96. PubMed ID: 14706012
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
Khan M; Khan AL; Khan S; Nawaz H
J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
[TBL] [Abstract][Full Text] [Related]
11. The Reten-World survey of the management of acute urinary retention: preliminary results.
Emberton M; Fitzpatrick JM
BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
[TBL] [Abstract][Full Text] [Related]
12. [Clinical outcomes after combined therapy with dutasteride in patients with unsuccessful trial without catheter after treatment with an alpha1-adrenergic receptor blocker monotherapy for acute urinary retention caused by prostatic hyperplasia].
Inahara M; Sugiura M; Kaga K; Hou K; Araki K; Masuda H; Kojima S; Naya Y
Nihon Hinyokika Gakkai Zasshi; 2014 Oct; 105(4):190-5. PubMed ID: 25757349
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
14. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
Bansal A; Arora A
Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
[TBL] [Abstract][Full Text] [Related]
15. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
Pandit RK; Agrawal CS; Chalise PR; Sapkota G
Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
[TBL] [Abstract][Full Text] [Related]
18. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; DamiĆ£o R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of conservatively managed acute urinary retention: prostate size matters.
Kumar V; Marr C; Bhuvangiri A; Irwin P
BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.
Kumar S; Tiwari DP; Ganesamoni R; Singh SK
Urology; 2013 Jul; 82(1):171-5. PubMed ID: 23561712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]